{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:44:49Z","timestamp":1787931889906,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,4]],"date-time":"2012-07-04T00:00:00Z","timestamp":1341360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10585-012-9506-0","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T16:25:27Z","timestamp":1341332727000},"page":"47-68","source":"Crossref","is-referenced-by-count":55,"title":["Dipyridamole prevents triple-negative breast-cancer progression"],"prefix":"10.1007","volume":"30","author":[{"given":"Daniela","family":"Spano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Nunzia","family":"Scoppettuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Di Dato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Medaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Steeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Zollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,4]]},"reference":[{"key":"9506_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"9506_CR2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","volume":"12","author":"PS Steeg","year":"2006","unstructured":"Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895\u2013904","journal-title":"Nat Med"},{"key":"9506_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10557-005-4659-6","volume":"19","author":"W Schaper","year":"2005","unstructured":"Schaper W (2005) Dipyridamole, an underestimated vascular protective drug. Cardiovasc Drugs Ther 19:357\u2013363","journal-title":"Cardiovasc Drugs Ther"},{"key":"9506_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0065-2571(93)90021-5","volume":"33","author":"JA Belt","year":"1993","unstructured":"Belt JA, Marina NM, Phelps DA, Crawford CR (1993) Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul 33:235\u2013252","journal-title":"Adv Enzyme Regul"},{"key":"9506_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10637-005-4541-1","volume":"24","author":"J Walling","year":"2006","unstructured":"Walling J (2006) From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates. Invest New Drugs 24:37\u201377","journal-title":"Invest New Drugs"},{"key":"9506_CR6","first-page":"3178","volume":"49","author":"SB Howell","year":"1989","unstructured":"Howell SB, Hom D, Sanga R, Vick JS, Abramson IS (1989) Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole. Cancer Res 49:3178\u20133183","journal-title":"Cancer Res"},{"key":"9506_CR7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ijc.2910430324","volume":"43","author":"N Ramu","year":"1989","unstructured":"Ramu N, Ramu A (1989) Circumvention of adriamycin resistance by dipyridamole analogues: a structure-activity relationship study. Int J Cancer 43:487\u2013491","journal-title":"Int J Cancer"},{"key":"9506_CR8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s002800050022","volume":"45","author":"NL Lehman","year":"2000","unstructured":"Lehman NL, Danenberg PV (2000) Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy. Cancer Chemother Pharmacol 45:142\u2013148","journal-title":"Cancer Chemother Pharmacol"},{"key":"9506_CR9","first-page":"2493","volume":"44","author":"JA Nelson","year":"1984","unstructured":"Nelson JA, Drake S (1984) Potentiation of methotrexate toxicity by dipyridamole. Cancer Res 44:2493\u20132496","journal-title":"Cancer Res"},{"key":"9506_CR10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1023\/A:1018920903436","volume":"9","author":"PB Desai","year":"1992","unstructured":"Desai PB, Sridhar R (1992) Potentiation of cytotoxicity of mitoxantrone toward CHO-K1 cells in vitro by dipyridamole. Pharm Res 9:178\u2013181","journal-title":"Pharm Res"},{"key":"9506_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00001813-200201000-00003","volume":"13","author":"CR Boyer","year":"2002","unstructured":"Boyer CR, Karjian PL, Wahl GM, Pegram M, Neuteboom ST (2002) Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011. Anticancer Drugs 13:29\u201336","journal-title":"Anticancer Drugs"},{"key":"9506_CR12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1590\/S0100-879X2004000400017","volume":"37","author":"M Rodrigues","year":"2004","unstructured":"Rodrigues M, Barbosa F Jr, Perussi JR (2004) Dipyridamole increases the cytotoxicity of cisplatin in human larynx cancer cells in vitro. Braz J Med Biol Res 37:591\u2013599","journal-title":"Braz J Med Biol Res"},{"key":"9506_CR13","first-page":"289","volume":"8","author":"S Sato","year":"1993","unstructured":"Sato S, Kohno K, Hidaka K, Hisatsugu T, Kuwano M, Komiyama S (1993) Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor. Anticancer Drug Des 8:289\u2013297","journal-title":"Anticancer Drug Des"},{"key":"9506_CR14","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/0006-2952(86)90385-0","volume":"35","author":"DG Kennedy","year":"1986","unstructured":"Kennedy DG, Van den Berg HW, Clarke R, Murphy RF (1986) Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole. The role of methotrexate polyglutamates. Biochem Pharmacol 35:3053\u20133056","journal-title":"Biochem Pharmacol"},{"key":"9506_CR15","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1038\/sj.onc.1211008","volume":"27","author":"AE Goda","year":"2008","unstructured":"Goda AE, Yoshida T, Horinaka M, Yasuda T, Shiraishi T, Wakada M, Sakai T (2008) Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole. Oncogene 27:3435\u20133445","journal-title":"Oncogene"},{"key":"9506_CR16","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s11095-005-8384-4","volume":"22","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Gupta A, Wang H, Zhou L, Vethanayagam RR, Unadkat JD, Mao Q (2005) BCRP transports dipyridamole and is inhibited by calcium channel blockers. Pharm Res 22:2023\u20132034","journal-title":"Pharm Res"},{"key":"9506_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389200043489199","volume":"5","author":"A Haimeur","year":"2004","unstructured":"Haimeur A, Conseil G, Deeley RG, Cole SP (2004) The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5:21\u201353","journal-title":"Curr Drug Metab"},{"key":"9506_CR18","first-page":"803","volume-title":"Platelets","author":"WG Eisert","year":"2002","unstructured":"Eisert WG (2002) Dipyridamole. In: Michelson AD (ed) Platelets. Academic Press, Amsterdam, pp 803\u2013815"},{"key":"9506_CR19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3810\/pgm.2010.11.2238","volume":"122","author":"H White","year":"2010","unstructured":"White H, Jamieson DG (2010) Review of the ESPRIT Study: aspirin plus dipyridamole versus aspirin alone for prevention of vascular events after a noncardioembolic, mild-to-moderate ischemic stroke or transient ischemic attack. Postgrad Med 122:227\u2013229","journal-title":"Postgrad Med"},{"key":"9506_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2183\/pjab.84.189","volume":"84","author":"T Tsuruo","year":"2008","unstructured":"Tsuruo T, Fujita N (2008) Platelet aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser B Phys Biol Sci 84:189\u2013198","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"9506_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2006.10.002","volume":"10","author":"ML Nierodzik","year":"2006","unstructured":"Nierodzik ML, Karpatkin S (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10:355\u2013362","journal-title":"Cancer Cell"},{"key":"9506_CR22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1200\/JCO.2006.06.7637","volume":"25","author":"WH Isacoff","year":"2007","unstructured":"Isacoff WH, Bendetti JK, Barstis JJ, Jazieh AR, Macdonald JS, Philip PA (2007) Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. J Clin Oncol 25:1665\u20131669","journal-title":"J Clin Oncol"},{"key":"9506_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s002800000142","volume":"46","author":"JW Raschko","year":"2000","unstructured":"Raschko JW, Synold TW, Chow W, Coluzzi P, Hamasaki V, Leong LA, Margolin KA, Morgan RJ, Shibata SI, Somlo G, Tetef ML, Yen Y, ter Veer A, Doroshow JH (2000) A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A. Cancer Chemother Pharmacol 46:403\u2013410","journal-title":"Cancer Chemother Pharmacol"},{"key":"9506_CR24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00000421-200010000-00021","volume":"23","author":"PA Burch","year":"2000","unstructured":"Burch PA, Ghosh C, Schroeder G, Allmer C, Woodhouse CL, Goldberg RM, Addo F, Bernath AM, Tschetter LK, Windschitl HE, Cobau CD (2000) Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial. Am J Clin Oncol 23:534\u2013537","journal-title":"Am J Clin Oncol"},{"key":"9506_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2008.11.023","volume":"370","author":"J Wenzel","year":"2009","unstructured":"Wenzel J, Zeisig R, Fichtner I (2009) Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation. Int J Pharm 370:121\u2013128","journal-title":"Int J Pharm"},{"key":"9506_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-009-0448-4","volume":"121","author":"J Wenzel","year":"2010","unstructured":"Wenzel J, Zeisig R, Haider W, Habedank S, Fichtner I (2010) Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation. Breast Cancer Res Treat 121:13\u201322","journal-title":"Breast Cancer Res Treat"},{"key":"9506_CR27","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363:1938\u20131948","journal-title":"N Engl J Med"},{"key":"9506_CR28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.tiv.2005.12.008","volume":"20","author":"JZ Xing","year":"2006","unstructured":"Xing JZ, Zhu L, Gabos S, Xie L (2006) Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol in Vitro 20:995\u20131004","journal-title":"Toxicol in Vitro"},{"key":"9506_CR29","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1021\/pr7006522","volume":"7","author":"D Spano","year":"2008","unstructured":"Spano D, Cimmino F, Capasso M, D\u2019Angelo F, Zambrano N, Terracciano L, Iolascon A (2008) Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis. J Proteome Res 7:2642\u20132653","journal-title":"J Proteome Res"},{"key":"9506_CR30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1590\/S0100-879X2010007500091","volume":"43","author":"KA Chuang","year":"2010","unstructured":"Chuang KA, Lieu CH, Tsai WJ, Wu MH, Chen YC, Liao JF, Wang CC, Kuo YC (2010) Evaluation of anti-Wnt\/\u03b2-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system. Braz J Med Biol Res 43:931\u2013941","journal-title":"Braz J Med Biol Res"},{"key":"9506_CR31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cellsig.2007.10.031","volume":"20","author":"A Vlad","year":"2008","unstructured":"Vlad A, R\u00f6hrs S, Klein-Hitpass L, M\u00fcller O (2008) The first five years of the Wnt targetome. Cell Signal 20:795\u2013802","journal-title":"Cell Signal"},{"key":"9506_CR32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.CIR.0000154607.90506.45","volume":"111","author":"AS Weyrich","year":"2005","unstructured":"Weyrich AS, Denis MM, Kuhlmann-Eyre JR, Spencer ED, Dixon DA, Marathe GK, McIntyre TM, Zimmerman GA, Prescott SM (2005) Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation 111:633\u2013642","journal-title":"Circulation"},{"key":"9506_CR33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/FJC.0b013e31813542db","volume":"50","author":"S Chakrabarti","year":"2007","unstructured":"Chakrabarti S, Blair P, Wu C, Freedman JE (2007) Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effects. J Cardiovasc Pharmacol 50:449\u2013457","journal-title":"J Cardiovasc Pharmacol"},{"key":"9506_CR34","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1158\/1535-7163.MCT-07-2424","volume":"7","author":"G Sethi","year":"2008","unstructured":"Sethi G, Ahn KS, Sung B, Aggarwal BB (2008) Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis. Mol Cancer Ther 7:1604\u20131614","journal-title":"Mol Cancer Ther"},{"key":"9506_CR35","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ijc.20954","volume":"115","author":"H Kawakami","year":"2005","unstructured":"Kawakami H, Tomita M, Matsuda T, Ohta T, Tanaka Y, Fujii M, Hatano M, Tokuhisa T, Mori N (2005) Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax. Int J Cancer 115:967\u2013974","journal-title":"Int J Cancer"},{"key":"9506_CR36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156652410791316968","volume":"10","author":"A Mantovani","year":"2010","unstructured":"Mantovani A (2010) Molecular pathways linking inflammation and cancer. Curr Mol Med 10:369\u2013373","journal-title":"Curr Mol Med"},{"key":"9506_CR37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2353\/ajpath.2010.090526","volume":"176","author":"K Boye","year":"2010","unstructured":"Boye K, Maelandsmo GM (2010) S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176:528\u2013535","journal-title":"Am J Pathol"},{"key":"9506_CR38","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2006.08.041","volume":"131","author":"U Stein","year":"2006","unstructured":"Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, Schlag PM, Shoemaker RH (2006) The metastasis-associated gene S100A4 is a novel target of beta-catenin\/T-cell factor signaling in colon cancer. Gastroenterology 131:1486\u20131500","journal-title":"Gastroenterology"},{"key":"9506_CR39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1471-2407-10-241","volume":"10","author":"I Grotter\u00f8d","year":"2010","unstructured":"Grotter\u00f8d I, Maelandsmo GM, Boye K (2010) Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB. BMC Cancer 10:241","journal-title":"BMC Cancer"},{"key":"9506_CR40","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.99-0508com","volume":"14","author":"G Hask\u00f3","year":"2000","unstructured":"Hask\u00f3 G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, Marton A, Szab\u00f3 C (2000) Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 14:2065\u20132074","journal-title":"FASEB J"},{"key":"9506_CR41","first-page":"7206","volume":"50","author":"GT Budd","year":"1990","unstructured":"Budd GT, Jayaraj A, Grabowski D, Adelstein D, Bauer L, Boyett J, Bukowski R, Murthy S, Weick J (1990) Phase I trial of dipyridamole with 5-fluorouracil and folinic acid. Cancer Res 50:7206\u20137211","journal-title":"Cancer Res"},{"key":"9506_CR42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0360-3016(00)00755-0","volume":"48","author":"A Chakravarthy","year":"2000","unstructured":"Chakravarthy A, Abrams RA, Yeo CJ, Korman LT, Donehower RC, Hruban RH, Zahurek ML, Grochow LB, O\u2019Reilly S, Hurwitz H, Jaffee EM, Lillemoe KD, Cameron JL (2000) Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys 48:1089\u20131096","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9506_CR43","first-page":"5585","volume":"48","author":"JK Willson","year":"1988","unstructured":"Willson JK, Fischer PH, Tutsch K, Alberti D, Simon K, Hamilton RD, Bruggink J, Koeller JM, Tormey DC, Earhart RH, Ranhosky A, Trump DL (1988) Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage. Cancer Res 48:5585\u20135590","journal-title":"Cancer Res"},{"key":"9506_CR44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.1989.7.2.262","volume":"7","author":"R Goel","year":"1989","unstructured":"Goel R, Cleary SM, Horton C, Balis FM, Zimm S, Kirmani S, Howell SB (1989) Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole. J Clin Oncol 7:262\u2013269","journal-title":"J Clin Oncol"},{"key":"9506_CR45","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jnci\/83.9.621","volume":"83","author":"S Isonishi","year":"1991","unstructured":"Isonishi S, Kirmani S, Kim S, Plaxe SC, Braly PS, McClay EF, Howell SB (1991) Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole. J Natl Cancer Inst 83:621\u2013626","journal-title":"J Natl Cancer Inst"},{"key":"9506_CR46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/clpt.1982.42","volume":"31","author":"C Mahony","year":"1982","unstructured":"Mahony C, Wolfram KM, Cocchetto DM, Bjornsson TD (1982) Dipyridamol kinetics. Clin Pharmacol Ther 31:330\u2013338","journal-title":"Clin Pharmacol Ther"},{"key":"9506_CR47","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/sj.bjc.6690591","volume":"80","author":"NJ Curtin","year":"1999","unstructured":"Curtin NJ, Bowman KJ, Turner RN, Huang B, Loughlin PJ, Calvert AH, Golding BT, Griffin RJ, Newell DR (1999) Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding. Br J Cancer 80:1738\u20131746","journal-title":"Br J Cancer"},{"key":"9506_CR48","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1242\/jcs.01481","volume":"117","author":"C Huang","year":"2004","unstructured":"Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. J Cell Sci 117:4619\u20134628","journal-title":"J Cell Sci"},{"key":"9506_CR49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12307-009-0030-y","volume":"2","author":"P Kaler","year":"2009","unstructured":"Kaler P, Godasi BN, Augenlicht L, Klampfer L (2009) The NF-kappaB\/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1beta. Cancer Microenviron 2:69\u201380","journal-title":"Cancer Microenviron"},{"key":"9506_CR50","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1038\/sj.onc.1210230","volume":"26","author":"D Kim","year":"2007","unstructured":"Kim D, Rath O, Kolch W, Cho KH (2007) A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways. Oncogene 26:4571\u20134579","journal-title":"Oncogene"},{"key":"9506_CR51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MB:29:1:57","volume":"29","author":"D Chuderland","year":"2005","unstructured":"Chuderland D, Seger R (2005) Protein-protein interactions in the regulation of the extracellular signal-regulated kinase. Mol Biotechnol 29:57\u201374","journal-title":"Mol Biotechnol"},{"key":"9506_CR52","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","volume":"86","author":"G Solinas","year":"2009","unstructured":"Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86:1065\u20131073","journal-title":"J Leukoc Biol"},{"key":"9506_CR53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"9506_CR54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431\u2013436","journal-title":"Nature"},{"key":"9506_CR55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","volume":"431","author":"E Pikarsky","year":"2004","unstructured":"Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461\u2013466","journal-title":"Nature"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-012-9506-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-012-9506-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-012-9506-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T18:39:55Z","timestamp":1559241595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-012-9506-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,4]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["9506"],"URL":"https:\/\/doi.org\/10.1007\/s10585-012-9506-0","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,4]]}}}